pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·3h ago·1 min read
save

Biotech firms race to hire AI-savvy scientists as talent gap widens

Sep 16, 2026·read at BioSpace ↗Neutral

AI is becoming integral to biotech research and development, prompting companies to seek staff who can blend biology with machine learning and data engineering.

Recruiters say the hardest-to-find talent are not traditional data scientists or biologists but hybrid professionals who understand both fields and can translate scientific problems into AI solutions.

The BioSpace 2026 U.S. Life Sciences Employment Outlook report found that 64% of surveyed organizations were actively recruiting, with artificial intelligence identified as a priority hiring area.

This trend forces biotech firms across gene therapy, oncology and rare-disease areas to compete for a limited pool of interdisciplinary experts, intensifying hiring challenges.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “AI is changing the talent biotech companies compete to hire”

read at BioSpace ↗
1,024 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2
drugs
Rare Disease
topics
Gene Therapy (AAV)2Oncology2Rare Disease2

related stories

  • 19h agoSionna says good-bye to 46% of staffers, including execBioSpace
  • Aug 18Assessing shared failures with AI is key to cell and gene therapy’s evolutionBioSpace
  • Aug 7Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapyFierce Biotech
  • Aug 6CROs vs. biotechs: Finding the right fitBioSpace
  • Aug 5Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, PrasadBioSpace